HLA-C and neoplasm: At present, tumor-related immunomodulators have become an important method for BC treatment, and in this study, we found that DHCR7 expression is significantly correlated with the immunoinhibitor, immunostimulators, and MHC molecules, including CD96, CD48, and HLA-DPB1.